NOVEL TARGETS AGAINST OVARIAN CANCER

The present disclosure provides a method of treating ovarian cancer comprising administering an siRNA against CASC10, wherein the CASC10 gene expression is reduced following administration in ovarian cancer patients. La présente invention concerne une méthode de traitement du cancer de l'ovaire...

Full description

Saved in:
Bibliographic Details
Main Authors VIVAS-MEJIA, Pablo, NORIEGA, Ricardo
Format Patent
LanguageEnglish
French
Published 23.11.2023
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present disclosure provides a method of treating ovarian cancer comprising administering an siRNA against CASC10, wherein the CASC10 gene expression is reduced following administration in ovarian cancer patients. La présente invention concerne une méthode de traitement du cancer de l'ovaire comprenant l'administration d'un ARNsi contre CASC10, l'expression du gène CASC10 étant réduite après son administration chez des patients atteints d'un cancer de l'ovaire.
Bibliography:Application Number: WO2023US67238